Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05100771
Other study ID # DR210107
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 14, 2022
Est. completion date March 2025

Study information

Verified date June 2024
Source University Hospital, Tours
Contact Baptiste Morel
Phone 02 47 47 47 58
Email baptiste.morel@univ-tours.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Multicentre cross-sectional study with prospective recruitment comparing the detection rate of lesions on brain MRI without and with quantitative volumetry and T1 relaxometry information during the management of children with suspected focal epilepsy.


Description:

Focal epilepsies are a very heterogeneous group comprising epilepsies of structural, genetic, metabolic, immune and infectious etiologies. In daily practice, epilepsy is considered as structural if lesions are visible on brain MRI in a location consistent with electro-clinical data. In the absence of visible lesion and clinico-biological arguments for a genetic, metabolic, immune or infectious cause, these epilepsies can be divided into two groups: self-limited focal epilepsies (formerly called idiopathic or functional), such as benign epilepsy with centrotemporal spikes (SLECTS) and secondly epilepsies of unknown causes. This classification underlines the idea that a lesion might be responsible for the epileptic disease but could be invisible due to the lack of sensitivity of our current diagnostic methods, especially in imaging. The prevalence of patients with non lesional epilepsy defined by MRI is significantly higher in children (31%) than in adults (21%). Epileptic patients with normal conventional MRI have a lower chance of having surgery than those with lesions demonstrated by presurgical MRI and, if so, less chance of becoming seizure-free. It can be challenging to depict brain volume abnormalities in the pediatric population on MRI. The major challenge is therefore to raise sensitivity of brain imaging analysis. Voxel-based morphometric MRI post-processing in MRI-negative epilepsies can be a practical and valuable tool to aid subtle MRI abnormalities detection and confirm visually identified questionable abnormalities in patients with focal epilepsy. In this study, we prospectively included children with suspected focal epilepsy having a brain MRI using a MP2RAGE sequence and a post-processing morphometric analysis program (MAP) allowing us to obtain automatically both brain volumetry and T1 relaxometry. The MAP has been validated with reference ranges in healthy children. Our hypothesis was that the quantitative information will improve the sensitivity of brain MRI in children with suspected focal epilepsy. The objectives were to compare the rate of detection of a focal cerebral lesion on the brain MRI carried out during the exploration of suspected focal epilepsy without then with the quantitative volumetry and T1 relaxometry obtained in the inclusion center and then by double anonymized review.


Recruitment information / eligibility

Status Recruiting
Enrollment 240
Est. completion date March 2025
Est. primary completion date March 2025
Accepts healthy volunteers No
Gender All
Age group 1 Year to 18 Years
Eligibility Inclusion Criteria: - Patient aged 1-18 years - Referred or followed by a pediatrician for epilepsy with focal onset - Requiring brain MRI as part of the work-up Exclusion Criteria: - Opposition of the child and/or parent to data processing - MRI not interpretable - Clinical and epileptic data not available or not specifying focus

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pediatric brain MRI
Routine brain MRI with automated quantitative information (brain volumetry and T1 relaxometry)

Locations

Country Name City State
France CHU Angers Angers
France CHU Grenoble Grenoble
France CHU Montpellier Montpellier
France CHU Rennes Rennes
France Hôpital Clocheville Tours

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Tours

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary rate of detection of a focal cerebral lesion on the brain MRI carried out during the exploration of suspected focal epilepsy without then with the quantitative volumetry and T1 relaxometry obtained in the inclusion center and then by double anonymized review Inclusion visit
Secondary Radiologist's confidence level in detecting lesions seen on MRI without the automated quantitative data Measured by a semi-quantitative visual analogue scale in the detection of brain lesions observed on MRI Inclusion visit
Secondary Radiologist's confidence level in detecting lesions seen on MRI with the automated quantitative data Measured by a semi-quantitative visual analogue scale in the detection of brain lesions observed on MRI Inclusion visit
Secondary pediatric brain MRIs interpretation without the additional quantitative brain information Inter-observer agreement in terms of normal or not normal MRI and in case of abnormality, the type of abnormality Inclusion visit
Secondary pediatric brain MRIs interpretation with the additional quantitative brain information Inter-observer agreement in terms of normal or not normal MRI and in case of abnormality, the type of abnormality Inclusion visit
Secondary Clinical examination Assessed by weight in kgs and height in cm, International League against epilepsy ( ILAE) classification Inclusion visit
Secondary electroencephalography Assessed by focal abnormalities and area Inclusion visit
Secondary Presentation of brain volumetry and T1 relaxometry in table form and map form pourcentage of choice between the table form and the map form depending on the radiologists Inclusion visit
See also
  Status Clinical Trial Phase
Recruiting NCT02245061 - Cortical Excitability Assessment Using Paired Pulses N/A
Terminated NCT05081518 - A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy Phase 1
Withdrawn NCT05481905 - ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures Phase 2
Completed NCT02208492 - The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study Phase 4
Recruiting NCT04839601 - RNS System RESPONSE Study N/A
Completed NCT02898935 - Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy
Enrolling by invitation NCT05748236 - The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy Phase 4
Terminated NCT01724918 - Lacosamide IV and EEG/EKG (LIVE) Study Phase 2
Completed NCT00855738 - A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice Phase 4
Recruiting NCT06309966 - Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Phase 2/Phase 3
Not yet recruiting NCT06210022 - Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy
Completed NCT01311440 - Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy N/A
Terminated NCT03955432 - Long-term Cardiac Monitoring in Epilepsy N/A
Recruiting NCT06132893 - A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Phase 2/Phase 3
Recruiting NCT04879433 - Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05198882 - Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy Phase 1
Recruiting NCT05981755 - Breathing Rescue for SUDEP Prevention N/A
Recruiting NCT03457961 - Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong
Not yet recruiting NCT06443463 - Long-term Safety and Tolerability of BHV-7000 Phase 2